| Pharmaceutical Information |
| Drug Name |
Nedocromil sodium |
| Drug ID |
BADD_D01545 |
| Description |
A pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with asthma, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets. |
| Indications and Usage |
For the treatment of mild to moderate asthma |
| Marketing Status |
approved; investigational |
| ATC Code |
S01GX04; R01AC07; R03BC03 |
| DrugBank ID |
DB00716
|
| KEGG ID |
D00527
|
| MeSH ID |
D017835
|
| PubChem ID |
50295
|
| TTD Drug ID |
D06FVX
|
| NDC Product Code |
82298-911; 0023-8842; 62255-1323 |
| UNII |
ET8IF4KS1T
|
| Synonyms |
Nedocromil | 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid | Alocril | Brionil | Nedocromil, Disodium salt, Hydrate | FPL-59002 | FPL 59002 | FPL59002 | Halamid | Nedocromil Calcium | Calcium, Nedocromil | Nedocromil, Calcium Salt (1:1) | Nedocromil Sodium | Sodium, Nedocromil | Nedocromil, Disodium Salt | Tilade | Irtan | Tilaire | Rapitil | Tilad | Tilavist | Cetimil |
|
| Chemical Information |
| Molecular Formula |
C19H15NNa2O7 |
| CAS Registry Number |
69049-74-7 |
| SMILES |
CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)[O-])C(=O)C=C(N2CC)C(=O)[O-].[Na+].[Na+] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
